{
  "schema_version": "0.1.0",
  "case_id": "HR-ML004",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "ML004",
    "display_name": "Johnny Cash",
    "aliases": [
      "J. R. Cash",
      "The Man in Black"
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1932-02-26",
          "display": "February 26, 1932",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1932",
              "display": "1932",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0005"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Encyclopedia of Arkansas."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "2003-09-12",
          "display": "September 12, 2003",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "2003",
              "display": "2003",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0005"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the Encyclopedia of Arkansas."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-ML004-SYN",
      "ssn": "000-04-8125",
      "date_of_birth": "1955-02-26",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Gideon Hale, MD",
      "fictional_consultant": {
        "name": "Ayesha Rahimi, MD",
        "specialty": "Endocrinology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1932-02-26",
        "display": "February 26, 1932",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born in Kingsland, Arkansas.",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1944",
        "display": "1944",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Older brother Jack died in a sawmill accident.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1957",
        "display": "1957",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Began taking amphetamines on the road; addiction lasted about a decade.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1983",
        "display": "1983",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Hospitalized with internal bleeding; then treated at the Betty Ford Clinic.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1997-10",
        "display": "October 1997",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Diagnosed with Shy-Drager syndrome, later called a misdiagnosis.",
      "claim_ids": [
        "CLM-0006"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "2001-02",
        "display": "February 2001",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Treated for pneumonia at Baptist Hospital in Nashville.",
      "claim_ids": [
        "CLM-0008"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "2002-11-26",
        "display": "November 26, 2002",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Described autonomic neuropathy, diabetes, glaucoma, and loss of about 60 percent of his vision in a televised interview.",
      "claim_ids": [
        "CLM-0007",
        "CLM-0008",
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0008",
      "date": {
        "iso": "2003-09-12",
        "display": "September 12, 2003",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Died at Baptist Hospital in Nashville of complications of diabetes with respiratory failure.",
      "claim_ids": [
        "CLM-0002"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "J. R. (Johnny) Cash was born on February 26, 1932, in Kingsland, Cleveland County, Arkansas, to Ray and Carrie Cash.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "Cash died at Baptist Hospital in Nashville, Tennessee, on September 12, 2003; his manager, Lou Robin, said in a statement issued by the hospital that he died of complications from diabetes, which resulted in respiratory failure.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Public statement by his manager; the documented basis for the diabetes in this case. Record the death without graphic detail.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "Cash's older brother Jack died in a sawmill accident in 1944.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Family event; an injury, not a heritable condition.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "In 1957 Cash began taking amphetamines to stay awake on a long road trip, the start of an addiction that lasted about a decade; in a 2002 interview he named amphetamines and barbiturates in the 1960s.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Historical substance use made public by Cash and his biographers. It is not a modern diagnosis in this case.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Cash: \"In the '60s, amphetamines and barbiturates.\""
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0005",
      "statement": "Cash was hospitalized in 1983 with internal bleeding; after recovering he entered the Betty Ford Clinic for treatment.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Historical treatment for substance use; the cited encyclopedia states he remained abstinent afterward.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0006",
      "statement": "In October 1997 Cash was diagnosed with Shy-Drager syndrome, an illness similar to Parkinson's disease; in a 2000 interview he said the diagnosis was a misdiagnosis.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "The diagnosis and its withdrawal were both made public by Cash. The case uses the withdrawn label as a teaching point about autonomic failure in diabetes.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "context",
          "locator": "Cash recounts the Shy-Drager diagnosis and its reversal; the rush transcript's dates differ from other reports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0007",
      "statement": "Cash later learned he had autonomic neuropathy; in November 2002 he described it as a deadening of the nerve endings in his lower extremities that had taken the strength from his legs, so that he could walk, but not very well.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Self-reported diagnosis; the anchor for the synthetic diabetic autonomic and peripheral neuropathy.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0008",
      "statement": "Cash was repeatedly hospitalized for pneumonia in his last years; he was treated for pneumonia at Baptist Hospital in Nashville in February 2001, and in November 2002 he said he had had pneumonia four times in three years.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0009",
      "statement": "In November 2002 Cash said about 60 percent of his vision was gone, which he attributed to the neuropathy and the diabetes, and he said he hoped the glaucoma could also be reversed.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "His own lay account; the type and stage of glaucoma and any retinal findings were not made public.",
      "source_links": [
        {
          "source_id": "SRC-0003",
          "relationship": "supports"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Johnny Cash (1932-2003)",
      "publisher": "CALS Encyclopedia of Arkansas",
      "url": "https://encyclopediaofarkansas.net/entries/johnny-cash-9/",
      "source_type": "scholarly",
      "published": null,
      "accessed": "2026-11-02",
      "rights_note": "Reference encyclopedia entry by Eric Lensing; facts used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Johnny Cash Battles Recurring Pneumonia",
      "publisher": "ABC News",
      "url": "https://abcnews.com/Entertainment/story?id=109597",
      "source_type": "other",
      "published": "2001-02-13",
      "accessed": "2026-11-02",
      "rights_note": "News report; facts used with citation."
    },
    {
      "source_id": "SRC-0003",
      "title": "Larry King Live: Interview With Johnny Cash (transcript)",
      "publisher": "CNN",
      "url": "https://transcripts.cnn.com/TRANSCRIPTS/0211/26/lkl.00.html",
      "source_type": "primary",
      "published": "2002-11-26",
      "accessed": "2026-11-02",
      "rights_note": "Rush broadcast transcript of Cash's own public statements; short quotations only."
    },
    {
      "source_id": "SRC-0004",
      "title": "Johnny Cash Dies",
      "publisher": "Pollstar",
      "url": "https://news.pollstar.com/2003/09/12/johnny-cash-dies/",
      "source_type": "other",
      "published": "2003-09-12",
      "accessed": "2026-11-02",
      "rights_note": "News report quoting the statement issued by Baptist Hospital; facts used with citation."
    },
    {
      "source_id": "SRC-0005",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-02",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-02-27",
    "index_age": 71,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Recognize that orthostatic lightheadedness, leg numbness, and falls in an older adult with long-standing type 2 diabetes fit diabetic autonomic and peripheral neuropathy rather than a prior label of Shy-Drager syndrome; set an individualized HbA1c goal, choose glucose-lowering drugs that avoid hypoglycemia, treat neurogenic orthostatic hypotension, and coordinate glaucoma care so that eye drops do not worsen blood pressure, using the CMID diabetes and glaucoma schedules.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-02-27",
        "purpose": "Primary care new-patient visit for diabetes, lightheadedness on standing, and glaucoma follow-up"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-03-27",
        "purpose": "Endocrinology consultation for diabetes and autonomic neuropathy"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-04-24",
        "purpose": "Subsequent annual wellness visit"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-05-29",
        "purpose": "Three-month diabetes, blood pressure, and eye pressure review"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-08-14",
        "purpose": "Six-month diabetes review with glaucoma imaging"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Type 2 diabetes mellitus with diabetic autonomic neuropathy; HbA1c above the individualized goal at intake",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.43",
            "display": "Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern diagnosis linked to the publicly reported diabetes and autonomic neuropathy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-002",
        "display": "Neurogenic orthostatic hypotension from diabetic autonomic neuropathy",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I95.1",
            "display": "Orthostatic hypotension",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic finding; explains the autonomic symptoms once labeled Shy-Drager syndrome.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-003",
        "display": "Diabetic distal symmetric polyneuropathy with loss of protective sensation in both feet",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.42",
            "display": "Type 2 diabetes mellitus with diabetic polyneuropathy",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic finding linked to his description of numb lower extremities.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-004",
        "display": "Primary open-angle glaucoma, both eyes, severe stage",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "H40.1133",
            "display": "Primary open-angle glaucoma, bilateral, severe stage",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern diagnosis; the type and stage are not documented historically.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-005",
        "display": "Mild nonproliferative diabetic retinopathy without macular edema, both eyes",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.3293",
            "display": "Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding from the dilated eye examination.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-006",
        "display": "Hyperlipidemia",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E78.5",
            "display": "Hyperlipidemia, unspecified",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding from the baseline LDL cholesterol.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-007",
        "display": "History of recurrent pneumonia",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "Z87.01",
            "display": "Personal history of pneumonia (recurrent)",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern coding of the documented recurrent pneumonia; supports pneumococcal vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Metformin 500 mg oral tablet, one tablet by mouth twice daily with meals",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "861007",
            "display": "metformin hydrochloride 500 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet by mouth twice daily with meals"
        },
        "start_date": "2024-05-06",
        "end_date": "2026-02-27",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic prior therapy at intake, increased at the first visit.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Metformin 1000 mg oral tablet, one tablet by mouth twice daily with meals",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "861004",
            "display": "metformin hydrochloride 1000 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet by mouth twice daily with meals"
        },
        "start_date": "2026-02-27",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metformin titration; eGFR above 45.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Sitagliptin 100 mg oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "665033",
            "display": "sitagliptin 100 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-03-27",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic add-on chosen by endocrinology for low hypoglycemia risk; a GLP-1 receptor agonist was deferred because slowed stomach emptying and nausea are a particular risk with autonomic neuropathy, and insulin and sulfonylureas were avoided because autonomic neuropathy can blunt hypoglycemia warning symptoms.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Atorvastatin 40 mg oral tablet, one tablet by mouth daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "617311",
            "display": "atorvastatin 40 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet by mouth daily"
        },
        "start_date": "2026-02-27",
        "indication_problem_ids": [
          "PRB-006"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic moderate-to-high-intensity statin for diabetes at age 40 to 75 with LDL above goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Latanoprost 0.005% ophthalmic solution, one drop in each eye at bedtime",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "314072",
            "display": "latanoprost 0.05 MG/ML Ophthalmic Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "{drop}"
        },
        "route": "ophthalmic",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One drop in each eye at bedtime"
        },
        "start_date": "2023-09-11",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic established first-line glaucoma therapy. Ophthalmic use is recorded under the topical route.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Dorzolamide 2% ophthalmic solution, one drop in each eye twice daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "310015",
            "display": "dorzolamide 20 MG/ML Ophthalmic Solution",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "{drop}"
        },
        "route": "ophthalmic",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One drop in each eye twice daily"
        },
        "start_date": "2026-02-27",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic second agent for pressure above target. Timolol was avoided because of bradycardia and bronchospasm risk, and brimonidine because it can lower blood pressure in a patient with orthostatic hypotension.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Midodrine 2.5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PM",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "993466",
            "display": "midodrine hydrochloride 2.5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One tablet by mouth on waking, at midday, and mid-afternoon; last dose at least four hours before bed"
        },
        "start_date": "2026-03-27",
        "end_date": "2026-05-29",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic starting dose for symptomatic neurogenic orthostatic hypotension after non-drug measures.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MED-008",
        "display": "Midodrine 5 mg oral tablet, one tablet by mouth three times daily, last dose by 6 PM",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "993470",
            "display": "midodrine hydrochloride 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 8,
          "period_unit": "h",
          "text": "One tablet by mouth on waking, at midday, and mid-afternoon; last dose at least four hours before bed"
        },
        "start_date": "2026-05-29",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic dose increase for persistent standing symptoms without supine hypertension.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "HbA1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 8.6,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 4.4,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 1.04,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 74,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 186,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V1",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 128,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V1",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 18,
        "unit": "mg/g",
        "reference_range": {
          "high": 30
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V1",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 24,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-AST-V1",
        "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "AST",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 22,
        "unit": "U/L",
        "reference_range": {
          "low": 10,
          "high": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1920-8",
            "display": "Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V1",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 286,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-02-27",
        "value": 13.8,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.2,
          "high": 16.6
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline result for the diabetes evaluation on the CMID annual schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-IOPOD-V1",
        "display": "Right eye Intraocular pressure",
        "label": "Intraocular pressure, right eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-27",
        "value": 22,
        "unit": "mm[Hg]",
        "reference_range": {
          "low": 10,
          "high": 21
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79892-6",
            "display": "Right eye Intraocular pressure",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic intraocular pressure above target on latanoprost alone.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-IOPOS-V1",
        "display": "Left eye Intraocular pressure",
        "label": "Intraocular pressure, left eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-27",
        "value": 24,
        "unit": "mm[Hg]",
        "reference_range": {
          "low": 10,
          "high": 21
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79893-4",
            "display": "Left eye Intraocular pressure",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic intraocular pressure above target on latanoprost alone.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-RNFLOD-V1",
        "display": "Right retina Retinal nerve fiber layer.mean thickness by OCT",
        "label": "Mean RNFL thickness by OCT, right eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-27",
        "value": 61,
        "unit": "um",
        "reference_range": {
          "low": 80,
          "high": 120
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "86301-9",
            "display": "Right retina Retinal nerve fiber layer.mean thickness by OCT",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic baseline OCT showing advanced nerve fiber layer thinning.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-RNFLOS-V1",
        "display": "Left retina Retinal nerve fiber layer.mean thickness by OCT",
        "label": "Mean RNFL thickness by OCT, left eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-27",
        "value": 57,
        "unit": "um",
        "reference_range": {
          "low": 80,
          "high": 120
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "86290-4",
            "display": "Left retina Retinal nerve fiber layer.mean thickness by OCT",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic baseline OCT showing advanced nerve fiber layer thinning.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAOD-V1",
        "display": "Visual acuity best corrected Right eye by ETDRS eye chart",
        "label": "Best-corrected visual acuity, right eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-27",
        "value": 68,
        "unit": "{letters}",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79876-9",
            "display": "Visual acuity best corrected Right eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic reduced best-corrected acuity from advanced glaucoma.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAOS-V1",
        "display": "Visual acuity best corrected Left eye by ETDRS eye chart",
        "label": "Best-corrected visual acuity, left eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-02-27",
        "value": 63,
        "unit": "{letters}",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79877-7",
            "display": "Visual acuity best corrected Left eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic reduced best-corrected acuity from advanced glaucoma.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V1",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-02-27",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-MINICOG-V1",
        "display": "Total score [Mini-Cog]",
        "label": "Mini-Cog",
        "status": "final",
        "effective_date": "2026-02-27",
        "value": 5,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72233-0",
            "display": "Total score [Mini-Cog]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic normal cognitive screen for an adult aged 65 or older.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V2",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-27",
        "value": 139,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at the endocrinology consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V2",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-27",
        "value": 4.3,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at the endocrinology consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V2",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-27",
        "value": 1.06,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at the endocrinology consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V2",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-27",
        "value": 72,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at the endocrinology consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V2",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-03-27",
        "value": 152,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel at the endocrinology consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V3",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "HbA1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-29",
        "value": 7.7,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month result after therapy changes.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V3",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-29",
        "value": 74,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month result after therapy changes.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-ALT-V3",
        "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
        "label": "ALT",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-05-29",
        "value": 27,
        "unit": "U/L",
        "reference_range": {
          "low": 7,
          "high": 56
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "1742-6",
            "display": "Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic three-month result after therapy changes.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-IOPOD-V3",
        "display": "Right eye Intraocular pressure",
        "label": "Intraocular pressure, right eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-05-29",
        "value": 15,
        "unit": "mm[Hg]",
        "reference_range": {
          "low": 10,
          "high": 21
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79892-6",
            "display": "Right eye Intraocular pressure",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic intraocular pressure at target after adding dorzolamide.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-IOPOS-V3",
        "display": "Left eye Intraocular pressure",
        "label": "Intraocular pressure, left eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-05-29",
        "value": 16,
        "unit": "mm[Hg]",
        "reference_range": {
          "low": 10,
          "high": 21
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79893-4",
            "display": "Left eye Intraocular pressure",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic intraocular pressure at target after adding dorzolamide.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V3",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-05-29",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V4",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "HbA1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-14",
        "value": 7.3,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month result on stable therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V4",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-14",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month result on stable therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V4",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-14",
        "value": 4.5,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month result on stable therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V4",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-14",
        "value": 1.05,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month result on stable therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V4",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-14",
        "value": 73,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month result on stable therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V4",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-14",
        "value": 131,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 99
        },
        "interpretation": "H",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month result on stable therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V4",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-08-14",
        "value": 16,
        "unit": "mg/g",
        "reference_range": {
          "high": 30
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic six-month result on stable therapy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-IOPOD-V4",
        "display": "Right eye Intraocular pressure",
        "label": "Intraocular pressure, right eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-14",
        "value": 14,
        "unit": "mm[Hg]",
        "reference_range": {
          "low": 10,
          "high": 21
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79892-6",
            "display": "Right eye Intraocular pressure",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic six-month eye-clinic result: pressure at target and no measurable progression.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-IOPOS-V4",
        "display": "Left eye Intraocular pressure",
        "label": "Intraocular pressure, left eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-14",
        "value": 15,
        "unit": "mm[Hg]",
        "reference_range": {
          "low": 10,
          "high": 21
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79893-4",
            "display": "Left eye Intraocular pressure",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic six-month eye-clinic result: pressure at target and no measurable progression.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-RNFLOD-V4",
        "display": "Right retina Retinal nerve fiber layer.mean thickness by OCT",
        "label": "Mean RNFL thickness by OCT, right eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-14",
        "value": 60,
        "unit": "um",
        "reference_range": {
          "low": 80,
          "high": 120
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "86301-9",
            "display": "Right retina Retinal nerve fiber layer.mean thickness by OCT",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic six-month eye-clinic result: pressure at target and no measurable progression.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-RNFLOS-V4",
        "display": "Left retina Retinal nerve fiber layer.mean thickness by OCT",
        "label": "Mean RNFL thickness by OCT, left eye",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-14",
        "value": 57,
        "unit": "um",
        "reference_range": {
          "low": 80,
          "high": 120
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "86290-4",
            "display": "Left retina Retinal nerve fiber layer.mean thickness by OCT",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic six-month eye-clinic result: pressure at target and no measurable progression.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAOD-V4",
        "display": "Visual acuity best corrected Right eye by ETDRS eye chart",
        "label": "Best-corrected visual acuity, right eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-14",
        "value": 68,
        "unit": "{letters}",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79876-9",
            "display": "Visual acuity best corrected Right eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic six-month eye-clinic result: pressure at target and no measurable progression.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-VAOS-V4",
        "display": "Visual acuity best corrected Left eye by ETDRS eye chart",
        "label": "Best-corrected visual acuity, left eye (ETDRS letters)",
        "status": "final",
        "category": "imaging",
        "effective_date": "2026-08-14",
        "value": 62,
        "unit": "{letters}",
        "reference_range": {
          "low": 80
        },
        "interpretation": "L",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "79877-7",
            "display": "Visual acuity best corrected Left eye by ETDRS eye chart",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic six-month eye-clinic result: pressure at target and no measurable progression.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-AWV",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-04-24",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic negative depression screen at the annual wellness visit.",
          "author": "The Human Record generator",
          "created": "2026-11-03T09:00:00-05:00"
        }
      },
      {
        "id": "OBS-AUDITC-AWV",
        "display": "Total score [AUDIT-C]",
        "label": "AUDIT-C",
        "status": "final",
        "effective_date": "2026-04-24",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "75626-2",
            "display": "Total score [AUDIT-C]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-03"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic routine alcohol screen at the annual wellness visit, consistent with the recorded social history.",
          "author": "The Human Record generator",
          "created": "2026-11-03T09:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "Comprehensive diabetic foot examination with 10-g monofilament and vibration testing",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "401191002",
            "display": "Diabetic foot examination",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-02-27",
          "end": "2026-02-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic annual foot examination; repeated at every visit because of sensory loss.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Optical coherence tomography of the optic nerve and retinal nerve fiber layer, both eyes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "700070005",
            "display": "Optical coherence tomography of retina",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-02-27",
          "end": "2026-02-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic baseline glaucoma imaging.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Dilated eye examination and Humphrey 24-2 visual field testing, both eyes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "392536003",
            "display": "Threshold automated static perimetry, central 24 degrees",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-02-27",
          "end": "2026-02-27"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic baseline visual field with dense arcuate defects in both eyes.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Optical coherence tomography of the optic nerve and retinal nerve fiber layer, both eyes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "700070005",
            "display": "Optical coherence tomography of retina",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-08-14",
          "end": "2026-08-14"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic six-month glaucoma imaging on the CMID schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Humphrey 24-2 visual field testing, both eyes",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "392536003",
            "display": "Threshold automated static perimetry, central 24 degrees",
            "validation_status": "validated",
            "validated_on": "2026-11-02"
          }
        ],
        "period": {
          "start": "2026-08-14",
          "end": "2026-08-14"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic six-month visual field without measurable progression.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "High-dose influenza vaccine, 2025-2026 season",
        "status": "completed",
        "date": "2025-10-20",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "135",
            "display": "Influenza, high-dose, trivalent, PF"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adult immunization history in the modern frame; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine PCV20",
        "status": "completed",
        "date": "2026-02-27",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic vaccination indicated at age 65 or older with diabetes and recurrent pneumonia.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Recombinant zoster vaccine, dose 1",
        "status": "completed",
        "date": "2026-05-29",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vaccination recommended at age 50 or older.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "family_history": [
      {
        "id": "FH-001",
        "relationship": {
          "system": "http://terminology.hl7.org/CodeSystem/v3-RoleCode",
          "code": "BRO",
          "display": "brother"
        },
        "condition": "Older brother Jack died in a sawmill accident in 1944",
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0003"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "Amphetamine use beginning in 1957, with barbiturates in the 1960s; addiction lasting about a decade",
        "historical_date": {
          "iso": "1957",
          "display": "1957",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PMH-002",
        "display": "Hospitalized in 1983 with internal bleeding, followed by treatment at the Betty Ford Clinic",
        "historical_date": {
          "iso": "1983",
          "display": "1983",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PMH-003",
        "display": "Diagnosed with Shy-Drager syndrome in October 1997; he said in 2000 that it was a misdiagnosis, and autonomic neuropathy was later identified",
        "historical_date": {
          "iso": "1997-10",
          "display": "October 1997",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "PMH-004",
        "display": "Pneumonia treated at Baptist Hospital in Nashville in February 2001, one of several pneumonia admissions",
        "historical_date": {
          "iso": "2001-02",
          "display": "February 2001",
          "precision": "month",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Primary care new-patient visit for diabetes, lightheadedness on standing, and glaucoma follow-up",
        "status": "finished",
        "date": "2026-02-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Endocrinology consultation for diabetes and autonomic neuropathy",
        "status": "finished",
        "date": "2026-03-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Endocrinology consultation and four-week diabetes check: lightheadedness on standing and choice of add-on glucose-lowering therapy",
          "hpi": {
            "narrative": "Mr. Cash is a 71-year-old man with type 2 diabetes, autonomic and peripheral neuropathy, and severe primary open-angle glaucoma, seen four weeks after his first visit for an endocrinology consultation on the same day as his diabetes check. Metformin was raised to 1000 mg twice daily, atorvastatin was started, and dorzolamide was added to latanoprost four weeks ago. He takes all of them, and metformin causes no stomach upset. His fasting home glucose readings run 140 to 170 mg/dL, with none below 70. He now stands up in stages, has raised the head of his bed, wears waist-high compression, and drinks about 2 liters a day. He is still lightheaded on standing most mornings and after meals, but he has had no further falls since the first visit. He asks again what he really has, since he was once told it was Shy-Drager syndrome.",
            "elements": [
              {
                "label": "Interval change",
                "value": "Lightheaded on standing most mornings and after meals; no further falls"
              },
              {
                "label": "Medication tolerance",
                "value": "No stomach upset on metformin 1000 mg twice daily; no muscle aches on atorvastatin; no eye stinging on dorzolamide"
              },
              {
                "label": "Home glucose",
                "value": "Fasting 140 to 170 mg/dL; none below 70"
              },
              {
                "label": "Non-drug measures",
                "value": "Staged standing, head of bed raised, waist-high compression, 2 liters of fluid a day"
              },
              {
                "label": "Patient question",
                "value": "What is causing the lightheadedness"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight down 1 kg; no fever"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Lightheaded on standing, worse in the morning and after meals; no fainting, chest pain, or palpitations"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, diarrhea, or early fullness"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No difficulty passing urine"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Numb feet to the ankles, unchanged; weak legs"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No shakiness, sweating, or confusion suggesting low glucose"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Alert and wry; walks in with a cane"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; blood pressure 150/84 mmHg lying, 142/78 mmHg seated, and 110/68 mmHg after three minutes standing, with heart rate 76 rising only to 80, and lightheadedness"
            },
            {
              "system": "Feet",
              "finding": "Skin intact; no ulcers or calluses; monofilament and vibration sensation reduced to the ankles; pedal pulses present"
            },
            {
              "system": "Neurological",
              "finding": "Reduced ankle reflexes; stocking sensory loss in both legs"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Neurogenic orthostatic hypotension from diabetic autonomic neuropathy",
              "assessment": "A fall of 32 mmHg in systolic pressure on standing with a rise of only 4 beats per minute in heart rate shows a neurogenic cause. With long-standing diabetes and length-dependent sensory loss in both legs, the pattern fits diabetic autonomic neuropathy, and the earlier Shy-Drager label is not carried forward in this record. He is still symptomatic despite non-drug measures, and lying pressure is 150/84 mmHg",
              "plan": [
                "Start midodrine 2.5 mg on waking, at midday, and mid-afternoon, with the last dose at least four hours before bed",
                "Continue staged standing, head-of-bed elevation, compression, and fluids",
                "Check lying, seated, and standing pressure at each visit"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes with diabetic autonomic neuropathy",
              "assessment": "HbA1c 8.6% four weeks ago, above his goal below 7.5%; fasting readings 140 to 170 on full-dose metformin. Sulfonylureas and insulin are avoided because autonomic neuropathy may blunt the warning signs of low glucose. eGFR 72 allows full-dose sitagliptin. Seated pressure is above 130/80, but with orthostatic hypotension no blood pressure medicine is used",
              "plan": [
                "Start sitagliptin 100 mg daily",
                "Continue metformin 1000 mg twice daily",
                "HbA1c at the three-month review"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Diabetic peripheral neuropathy with loss of protective sensation",
              "assessment": "No ulcer or pre-ulcerative lesion",
              "plan": [
                "Daily foot checks and protective shoes"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Primary open-angle glaucoma, severe stage",
              "assessment": "Dorzolamide added four weeks ago; no eye pressure check has been made since",
              "plan": [
                "Ask the eye clinic for a pressure check as soon as possible"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "Basic metabolic panel",
              "cadence": "Before choosing add-on therapy; yearly when eGFR is 60 or more",
              "status": "completed_today",
              "detail": "eGFR 72 and potassium 4.3: no dose change needed for metformin or sitagliptin, and safe to start midodrine",
              "observation_ids": [
                "OBS-NA-V2",
                "OBS-K-V2",
                "OBS-CR-V2",
                "OBS-EGFR-V2",
                "OBS-GLU-V2"
              ],
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "HbA1c",
              "cadence": "Every 3 months until at goal or after a therapy change; every 6 months when stable",
              "status": "up_to_date",
              "detail": "8.6% four weeks ago; next at the three-month review",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel after starting a statin",
              "cadence": "4 to 12 weeks after a statin starts or changes",
              "status": "due",
              "detail": "Atorvastatin started four weeks ago; draw within the next eight weeks",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, weight, and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Seated 142/78 mmHg; weight 95.0 kg, down 1 kg",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Lying, seated, and standing blood pressure",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Lying 150/84, standing 110/68 mmHg; heart rate 76 to 80. Baseline before midodrine",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Foot examination (inspection, pulses, monofilament)",
              "cadence": "Every visit with loss of protective sensation",
              "status": "completed_today",
              "detail": "No ulcer; sensory loss unchanged",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Tonometry (eye pressure)",
              "cadence": "Every glaucoma visit; 4 to 6 weeks after adding a drop",
              "status": "deferred",
              "detail": "Not measured at this visit, and no eye-clinic check has been booked since dorzolamide was added four weeks ago, a deviation from the plan. Request sent to the eye clinic",
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Hypoglycemia review and home glucose log",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No readings below 70 mg/dL and no symptoms of low glucose",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No tobacco use",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Metformin, atorvastatin, and dorzolamide tolerance",
              "cadence": "After each start or dose change",
              "status": "completed_today",
              "detail": "No stomach upset, muscle aches, or eye stinging",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Antihypertensive and other medicines that lower standing pressure",
              "cadence": "Every visit with orthostatic hypotension",
              "status": "completed_today",
              "detail": "None in use; timolol and brimonidine avoided",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-AAO-POAG-2025"
              ]
            },
            {
              "domain": "referral",
              "measure": "Endocrinology consultation",
              "cadence": "When the diagnosis or treatment of a complication is uncertain",
              "status": "completed_today",
              "detail": "Seen today: diabetic autonomic neuropathy confirmed as the working diagnosis, sitagliptin and midodrine started",
              "guideline_ids": [
                "GL-ADA-2025"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Orthostatic hypotension measures and foot self-care",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Staged standing, head-of-bed elevation, compression, fluids, and daily foot checks reviewed",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Annual wellness visit in four weeks. Three-month review with HbA1c, lipids, and an eye pressure check",
          "guideline_ids": [
            "GL-ADA-2025",
            "GL-CMID-2026",
            "GL-AAO-POAG-2025"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Three-month diabetes, blood pressure, and eye pressure review",
        "status": "finished",
        "date": "2026-05-29",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Three-month diabetes, blood pressure, and eye pressure review",
          "hpi": {
            "narrative": "Mr. Cash returns for his three-month review, nine weeks after sitagliptin and midodrine 2.5 mg were started and five weeks after his annual wellness visit. His fasting home readings now run 120 to 150 mg/dL, with none below 70. He is less lightheaded than before midodrine, but he still feels faint for a minute or two after getting up in the morning and after lunch, and he has had no falls. He takes the last midodrine by mid-afternoon and has no scalp tingling or trouble passing urine. He has started physical therapy for gait and balance, and the low-vision home visit is booked. He uses both eye drops every day without stinging. No eye pressure check was done between visits. He is writing and recording at home.",
            "elements": [
              {
                "label": "Interval change",
                "value": "Less lightheaded; still briefly faint after rising and after lunch; no falls"
              },
              {
                "label": "Home glucose",
                "value": "Fasting 120 to 150 mg/dL; none below 70"
              },
              {
                "label": "Midodrine tolerance",
                "value": "Last dose by mid-afternoon; no scalp tingling or urinary retention"
              },
              {
                "label": "Rehabilitation",
                "value": "Physical therapy started; low-vision home visit booked"
              },
              {
                "label": "Eye drops",
                "value": "Latanoprost and dorzolamide daily; no stinging"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight down 0.7 kg since the wellness visit; no fever"
            },
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Tunnel vision and poor vision in dim light, unchanged; no eye pain or redness"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Briefly faint after rising and after lunch; no fainting or chest pain"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No difficulty passing urine"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "No muscle aches on atorvastatin"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 score 0"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Alert and well; walks with a cane"
            },
            {
              "system": "Eyes",
              "finding": "Conjunctivae quiet; eye pressure 15 mmHg right and 16 mmHg left by applanation at the eye clinic today"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; blood pressure 146/82 mmHg lying, 136/76 mmHg seated, and 114/70 mmHg after three minutes standing, with lightheadedness"
            },
            {
              "system": "Feet",
              "finding": "Skin intact; no ulcers or calluses; sensory loss to the ankles unchanged; protective shoes"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Neurogenic orthostatic hypotension",
              "assessment": "Standing systolic pressure 114 mmHg on midodrine 2.5 mg, with symptoms after rising and after meals. Lying pressure 146/82 mmHg leaves room to raise the dose",
              "plan": [
                "Increase midodrine to 5 mg on waking, at midday, and mid-afternoon, with the last dose at least four hours before bed",
                "Smaller, lower-carbohydrate lunches to reduce the fall in pressure after meals",
                "Lying, seated, and standing pressure at the six-month review"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes with diabetic autonomic neuropathy",
              "assessment": "HbA1c 7.7%, down from 8.6% and close to his goal below 7.5%, with no hypoglycemia",
              "plan": [
                "Continue metformin and sitagliptin",
                "HbA1c at the six-month review"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Hyperlipidemia",
              "assessment": "LDL 74 mg/dL, down from 128 on atorvastatin 40 mg. That is a 42 percent fall, short of the 50 percent expected on a high-intensity dose and just above the goal below 70. He reports taking it every day. ALT 27 U/L, normal",
              "plan": [
                "Continue atorvastatin 40 mg and reinforce daily use",
                "Add ezetimibe if LDL is still 70 or more at the annual review",
                "Lipid panel at the annual review"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Primary open-angle glaucoma, severe stage",
              "assessment": "Eye pressures 15 and 16 mmHg, down from 22 and 24, meet the eye clinic's target of 16 or less. Neither drop lowers blood pressure or heart rate",
              "plan": [
                "Continue latanoprost and dorzolamide",
                "OCT and visual fields at six months with the eye clinic"
              ]
            },
            {
              "display": "Immunization and preventive care",
              "assessment": "PCV20 was given at the first visit; recombinant zoster vaccine was planned for today",
              "plan": [
                "Recombinant zoster vaccine dose 1 given today; dose 2 in two to six months",
                "Hepatitis C antibody drawn with today's tests, as planned at the wellness visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "HbA1c",
              "cadence": "Every 3 months until at goal or after a therapy change; every 6 months when stable",
              "status": "completed_today",
              "detail": "7.7%, down from 8.6%; not yet at goal, so repeat in three months",
              "observation_ids": [
                "OBS-A1C-V3"
              ],
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel after starting a statin",
              "cadence": "4 to 12 weeks after a statin starts or changes",
              "status": "completed_today",
              "detail": "LDL 74 mg/dL, a 42 percent fall. Drawn at 13 weeks, one week after the window closed, because the panel was scheduled for this review instead of inside the window: a minor deviation from the protocol. No harm resulted; there was no dose decision that an earlier result would have changed",
              "observation_ids": [
                "OBS-LDL-V3"
              ],
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "ALT",
              "cadence": "Once before a statin; afterward only for symptoms",
              "status": "completed_today",
              "detail": "27 U/L, normal; no further routine checks",
              "observation_ids": [
                "OBS-ALT-V3"
              ],
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "ALT, AST, and platelets for FIB-4",
              "cadence": "At diagnosis and yearly",
              "status": "deferred",
              "detail": "FIB-4 could not be calculated at intake because no platelet count was drawn with the hemoglobin, a deviation from the protocol. ALT and AST were normal at intake and ALT is normal today, so missed liver scarring is unlikely; AST and a platelet count are added to the annual tests",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipoprotein(a)",
              "cadence": "Once in adulthood",
              "status": "deferred",
              "detail": "Not yet measured, a deviation from the protocol. It would not change treatment now, since he already takes a high-intensity statin; added to the annual lipid panel",
              "guideline_ids": [
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, weight, and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Seated 136/76 mmHg; weight 93.5 kg",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Lying, seated, and standing blood pressure",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Lying 146/82, standing 114/70 mmHg; no supine hypertension",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Foot examination (inspection, pulses, monofilament)",
              "cadence": "Every visit with loss of protective sensation",
              "status": "completed_today",
              "detail": "No ulcer; sensory loss unchanged",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Tonometry (eye pressure)",
              "cadence": "Every glaucoma visit; 4 to 6 weeks after adding a drop",
              "status": "completed_today",
              "detail": "15 mmHg right and 16 mmHg left, at target. This is the first check since dorzolamide was added three months ago; the check at four to six weeks was missed (see the four-week note). The pressure has reached target, and the six-month OCT and fields will show whether the delay cost any nerve tissue",
              "observation_ids": [
                "OBS-IOPOD-V3",
                "OBS-IOPOS-V3"
              ],
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Drop adherence, ocular surface, and systemic effects of glaucoma drops",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Both drops used daily; no stinging; no effect on pulse or blood pressure",
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "OCT of the optic nerve and nerve fiber layer, and visual fields",
              "cadence": "Every 6 months in severe glaucoma",
              "status": "due",
              "detail": "At the six-month review with the eye clinic",
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Hypoglycemia review and home glucose log",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No readings below 70 mg/dL",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-2)",
              "cadence": "At least yearly",
              "status": "completed_today",
              "detail": "Score 0",
              "observation_ids": [
                "OBS-PHQ2-V3"
              ],
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No tobacco use",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Midodrine safety: lying pressure, timing, and urinary retention",
              "cadence": "Every visit on midodrine",
              "status": "completed_today",
              "detail": "Lying 146/82 mmHg; last dose by mid-afternoon; no retention",
              "guideline_ids": [
                "GL-ADA-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccination review",
              "cadence": "Yearly, and as doses fall due",
              "status": "completed_today",
              "detail": "Recombinant zoster dose 1 given today; RSV, COVID-19, and tetanus remain due from the wellness visit",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Physical therapy and low-vision rehabilitation",
              "cadence": "After a fall-risk finding",
              "status": "completed_today",
              "detail": "Physical therapy under way; low-vision home visit booked",
              "guideline_ids": [
                "GL-USPSTF-FALLS-2024",
                "GL-AAO-POAG-2025"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Diet, orthostatic measures, and foot self-care",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Smaller lunches added; other measures continue",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Six-month diabetes review with HbA1c, a basic metabolic panel, urine albumin-creatinine ratio, eye pressure, OCT, and visual fields",
          "guideline_ids": [
            "GL-ADA-2025",
            "GL-CMID-2026",
            "GL-AAO-POAG-2025"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Six-month diabetes review with glaucoma imaging",
        "status": "finished",
        "date": "2026-08-14",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Six-month diabetes review with glaucoma imaging",
          "hpi": {
            "narrative": "Mr. Cash returns for his six-month review. Since midodrine was raised to 5 mg he rarely feels lightheaded, only if he stands quickly after lunch, and he has had no falls. He finished physical therapy and does the home exercises most days. The low-vision therapist reviewed his home lighting, and a second stair handrail is in place. His fasting home readings run 110 to 140 mg/dL, with none below 70. He has no scalp tingling or trouble passing urine and takes the last midodrine by mid-afternoon. He uses both eye drops daily and notices no change in his vision. The FIT kit from the wellness visit has not been returned.",
            "elements": [
              {
                "label": "Interval change",
                "value": "Rarely lightheaded on midodrine 5 mg; no falls"
              },
              {
                "label": "Home glucose",
                "value": "Fasting 110 to 140 mg/dL; none below 70"
              },
              {
                "label": "Rehabilitation",
                "value": "Physical therapy finished; home exercises; second stair handrail fitted"
              },
              {
                "label": "Vision",
                "value": "No change noticed"
              },
              {
                "label": "Open items",
                "value": "FIT kit not returned"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight down 1 kg; no fever"
            },
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Tunnel vision, unchanged; no eye pain"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No fainting; lightheaded only on standing quickly after lunch"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or breathlessness"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No difficulty passing urine"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No symptoms of low glucose"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Alert and well; walks with a cane"
            },
            {
              "system": "Eyes",
              "finding": "Eye clinic today: pressure 14 mmHg right and 15 mmHg left; best-corrected acuity 68 letters right and 62 left; optic nerve appearance unchanged from intake"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; blood pressure 148/82 mmHg lying, 134/74 mmHg seated, and 120/70 mmHg after three minutes standing, without symptoms"
            },
            {
              "system": "Feet",
              "finding": "Skin intact; no ulcers or calluses; sensory loss to the ankles unchanged; pedal pulses present"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes with diabetic autonomic neuropathy",
              "assessment": "HbA1c 7.3%, below his goal of 7.5%, with no hypoglycemia. Kidney screening normal: eGFR 73 and urine albumin-creatinine ratio 16 mg/g",
              "plan": [
                "Continue metformin 1000 mg twice daily and sitagliptin 100 mg daily",
                "HbA1c every six months now that he is at goal"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Neurogenic orthostatic hypotension",
              "assessment": "Standing systolic pressure 120 mmHg on midodrine 5 mg, above the goal of 100, and no falls. Lying pressure 148/82 mmHg, with no supine hypertension",
              "plan": [
                "Continue midodrine 5 mg three times daily and the non-drug measures"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Primary open-angle glaucoma, severe stage",
              "assessment": "Eye pressures 14 and 15 mmHg. Nerve fiber layer thickness is unchanged (60 and 57 µm, against 61 and 57 at intake), acuity is stable, and the 24-2 fields show no new defect against intake, so the pressure check missed in the spring caused no measurable loss",
              "plan": [
                "Continue latanoprost and dorzolamide",
                "Eye clinic review in three to six months; OCT and fields every six months; add a 10-2 field test at the next field visit"
              ]
            },
            {
              "problem_id": "PRB-005",
              "display": "Mild nonproliferative diabetic retinopathy",
              "assessment": "No change reported by the eye clinic",
              "plan": [
                "Dilated retinal examination yearly"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Hyperlipidemia",
              "assessment": "LDL 74 mg/dL three months ago, just above the goal below 70",
              "plan": [
                "Lipid panel with lipoprotein(a) at the annual review"
              ]
            },
            {
              "display": "Preventive care",
              "assessment": "The hepatitis C antibody drawn at the last visit has no result on file, and the FIT kit has not been returned",
              "plan": [
                "Result requested from the laboratory",
                "Reminder given to return the FIT kit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "laboratory",
              "measure": "HbA1c",
              "cadence": "Every 3 months until at goal or after a therapy change; every 6 months when stable",
              "status": "completed_today",
              "detail": "7.3%, at goal; repeat every six months",
              "observation_ids": [
                "OBS-A1C-V4"
              ],
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Basic metabolic panel and urine albumin-creatinine ratio",
              "cadence": "Yearly when eGFR is 60 or more and albumin is normal",
              "status": "completed_today",
              "detail": "eGFR 73; potassium 4.5; urine albumin-creatinine ratio 16 mg/g. Repeated at six months because he takes full-dose metformin and midodrine, which the kidney clears",
              "observation_ids": [
                "OBS-NA-V4",
                "OBS-K-V4",
                "OBS-CR-V4",
                "OBS-EGFR-V4",
                "OBS-GLU-V4",
                "OBS-UACR-V4"
              ],
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Lipid panel",
              "cadence": "Every 3 to 12 months until stable, then yearly",
              "status": "due",
              "detail": "LDL 74 three months ago; at the annual review with lipoprotein(a)",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Vitamin B12 on metformin",
              "cadence": "Periodically on long-term metformin, especially with neuropathy",
              "status": "due",
              "detail": "286 pg/mL at intake, low-normal with neuropathy; repeat at the annual review, with methylmalonic acid if still below 300",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "ALT, AST, and platelets for FIB-4",
              "cadence": "At diagnosis and yearly",
              "status": "due",
              "detail": "AST and a platelet count added to the annual tests after the gap noted at three months",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, weight, and BMI",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Seated 134/74 mmHg; weight 92.5 kg, down 3.5 kg since intake",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Lying, seated, and standing blood pressure",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Lying 148/82, standing 120/70 mmHg; goal of a standing systolic pressure of 100 or more met",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Foot examination (inspection, pulses, monofilament)",
              "cadence": "Every visit with loss of protective sensation",
              "status": "completed_today",
              "detail": "No ulcer; sensory loss unchanged",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dental examination",
              "cadence": "Yearly",
              "status": "due",
              "detail": "No dental examination on record; advised to see his dentist",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Tonometry (eye pressure)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "14 mmHg right and 15 mmHg left",
              "observation_ids": [
                "OBS-IOPOD-V4",
                "OBS-IOPOS-V4"
              ],
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Best-corrected visual acuity",
              "cadence": "Each comprehensive eye examination",
              "status": "completed_today",
              "detail": "68 letters right and 62 left, against 68 and 63 at intake",
              "observation_ids": [
                "OBS-VAOD-V4",
                "OBS-VAOS-V4"
              ],
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Drop adherence, ocular surface, and systemic effects of glaucoma drops",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Both drops used daily; no ocular surface irritation; no systemic effect",
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "OCT of the optic nerve and nerve fiber layer",
              "cadence": "Every 6 to 12 months; every 6 months in severe glaucoma",
              "status": "completed_today",
              "detail": "60 µm right and 57 µm left, against 61 and 57 at intake: no structural progression",
              "observation_ids": [
                "OBS-RNFLOD-V4",
                "OBS-RNFLOS-V4"
              ],
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Visual field (Humphrey 24-2)",
              "cadence": "Every 6 to 12 months",
              "status": "completed_today",
              "detail": "No new defect against intake",
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Visual field (Humphrey 10-2)",
              "cadence": "In advanced disease, alongside the 24-2",
              "status": "deferred",
              "detail": "Not done at intake or today, a deviation from the protocol for severe glaucoma. The 24-2 and OCT are stable, so loss near fixation is unlikely to have been missed; the eye clinic will add a 10-2 at the next field visit",
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Gonioscopy and corneal thickness",
              "cadence": "At the initial evaluation; repeat only with an unexplained pressure change",
              "status": "not_indicated",
              "detail": "Baseline measures belong to the eye clinic's initial evaluation; the pressure response has been as expected",
              "guideline_ids": [
                "GL-AAO-POAG-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Hypoglycemia review and home glucose log",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No readings below 70 mg/dL",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Diabetes distress, anxiety (GAD-7), disordered eating, and social needs screens",
              "cadence": "Yearly",
              "status": "due",
              "detail": "Not yet done this year; at the annual review",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Cognitive screen and fall risk",
              "cadence": "Yearly at 65 or older",
              "status": "up_to_date",
              "detail": "Mini-Cog 5 of 5 at intake; Timed Up and Go 14 seconds at the wellness visit",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "10-year cardiovascular risk (PREVENT)",
              "cadence": "Yearly from 40 to 75 without cardiovascular disease",
              "status": "not_indicated",
              "detail": "He already takes a high-intensity statin for diabetes with complications, so the score would not change treatment",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Tobacco use",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No tobacco use",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Midodrine safety: lying pressure, timing, and urinary retention",
              "cadence": "Every visit on midodrine",
              "status": "completed_today",
              "detail": "Lying 148/82 mmHg; no retention",
              "guideline_ids": [
                "GL-ADA-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Vaccination review",
              "cadence": "Yearly, and as doses fall due",
              "status": "due",
              "detail": "Recombinant zoster dose 2 is due within six months of dose 1, at his pharmacy, alongside the seasonal influenza vaccine; RSV and COVID-19 before the respiratory season; tetanus booster",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Diabetes self-management education and medical nutrition therapy",
              "cadence": "At diagnosis, yearly, with new complications, and at care transitions",
              "status": "referred",
              "detail": "Not arranged in the first six months despite two medication changes, a deviation from the protocol. No harm resulted, since HbA1c reached goal without hypoglycemia. Referred today to an individual program with large-print materials because of his vision",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Exercise, diet, orthostatic measures, and foot self-care",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Home exercises most days; smaller lunches; daily foot checks",
              "guideline_ids": [
                "GL-ADA-2025",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Eye clinic review in three to six months. Diabetes review in six months with HbA1c. Annual review with lipids, lipoprotein(a), vitamin B12, AST, platelet count, and the yearly screens",
          "guideline_ids": [
            "GL-ADA-2025",
            "GL-CMID-2026",
            "GL-AAO-POAG-2025"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Subsequent annual wellness visit",
        "status": "finished",
        "date": "2026-04-24",
        "visit_type": "annual_wellness_subsequent",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "281038008",
          "display": "Geriatric annual health check",
          "validation_status": "validated",
          "validated_on": "2026-11-03"
        },
        "documentation": {
          "chief_complaint": "Subsequent annual wellness visit; no new complaints",
          "billing_note": "HCPCS G0439 (subsequent annual wellness visit) with CPT 99497 (advance care planning), both on the same day",
          "hpi": {
            "narrative": "Mr. Cash is a 71-year-old man with type 2 diabetes complicated by autonomic and peripheral neuropathy, neurogenic orthostatic hypotension, and severe primary open-angle glaucoma, who returns for his subsequent annual wellness visit four weeks after his endocrinology consultation. Sitagliptin and low-dose midodrine were started then. He completed the health risk assessment before the visit, with a family member reading the questions aloud because of his low vision. He stands up in stages, sleeps with the head of the bed raised, and wears waist-high compression; the lightheadedness on standing is less frequent, and he has had no falls since the consultation. His home glucose readings show no values below 70 mg/dL. He uses both eye drops as prescribed and has added no over-the-counter medicines. He is recording at home and writing most days.",
            "elements": [
              {
                "label": "Visit",
                "value": "Subsequent annual wellness visit"
              },
              {
                "label": "Context",
                "value": "Health risk assessment completed before the visit with a family member reading the questions"
              },
              {
                "label": "Safety events",
                "value": "No falls since the endocrinology consultation; no emergency visits or hospital stays since his first visit"
              },
              {
                "label": "Medicines",
                "value": "Adherent; pill organizer filled by a family member; both eye drops in use; no new over-the-counter medicines"
              },
              {
                "label": "Active conditions",
                "value": "Type 2 diabetes with autonomic and peripheral neuropathy, orthostatic hypotension, glaucoma, mild diabetic retinopathy, and hyperlipidemia"
              },
              {
                "label": "Functional status",
                "value": "Independent in basic activities of daily living; walks with a cane; does not drive"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Fair, and better since standing up has become easier"
            },
            {
              "domain": "Psychosocial",
              "finding": "A family member helps at home and comes to visits; active church community; writing and recording at home give purpose; no loneliness reported"
            },
            {
              "domain": "Behavioral",
              "finding": "No tobacco use; no alcohol; walks short distances with a cane; follows a carbohydrate-consistent diet; sleeps about seven hours"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in bathing, dressing, eating, toileting, and transfers"
            },
            {
              "domain": "Instrumental activities of daily living",
              "finding": "Manages his own money and telephone; a family member fills his pill organizer and drives him"
            },
            {
              "domain": "Home safety",
              "finding": "Smoke detectors working; dim hallway and stair lighting; handrail on one side of the stairs only"
            },
            {
              "domain": "Falls",
              "finding": "Two falls in the six months before his first visit, none since the consultation; afraid of falling again"
            },
            {
              "domain": "Hearing and vision",
              "finding": "No hearing concern; tunnel vision and difficulty in dim light from glaucoma; dilated eye examination two months ago"
            },
            {
              "domain": "Bladder",
              "finding": "No urgency, incontinence, or difficulty emptying"
            },
            {
              "domain": "Memory",
              "finding": "No concerns from him or his family"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "Weight down about 1 kg since the consultation with diet; no fever or appetite change"
            },
            {
              "system": "Eyes",
              "status": "positive",
              "finding": "Long-standing tunnel vision and poor vision in dim light; no eye pain, redness, or stinging from the drops"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "negative",
              "finding": "No hearing change or mouth sores"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Lightheaded on standing quickly, less often than before; no fainting, chest pain, palpitations, or ankle swelling"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough, sputum, or breathlessness"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, diarrhea, or constipation on metformin"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "No urinary urgency, incontinence, or retention"
            },
            {
              "system": "Musculoskeletal",
              "status": "positive",
              "finding": "Leg weakness; walks with a cane; no falls since the consultation"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No foot sores, blisters, or color change on daily foot checks"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Numbness of both feet to the ankles, unchanged; no new weakness or headache"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; sleeps well; PHQ-2 score 0"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No shakiness, sweating, or confusion suggesting low glucose; no excess thirst or urination"
            },
            {
              "system": "Hematologic",
              "status": "negative",
              "finding": "No easy bruising or bleeding"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Alert, wry, and well-appearing; weight 94.2 kg, down from 95.0 kg at the consultation"
            },
            {
              "system": "Eyes",
              "finding": "Conjunctivae quiet; pupils equal; constricted fields to confrontation in both eyes"
            },
            {
              "system": "Ears, nose, and throat",
              "finding": "Canals clear; oral mucosa moist"
            },
            {
              "system": "Neck",
              "finding": "No thyroid enlargement or nodes; no carotid bruits"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; blood pressure 138/76 mmHg seated and 116/70 mmHg after three minutes standing, heart rate 75 to 78, with mild lightheadedness; no edema"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation bilaterally"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender; no masses or aortic bruit"
            },
            {
              "system": "Feet",
              "finding": "Skin intact with no ulcers or calluses; 10-g monofilament and vibration sensation reduced to the ankles in both feet; dorsalis pedis and posterior tibial pulses present; well-fitting protective shoes"
            },
            {
              "system": "Musculoskeletal",
              "finding": "Timed Up and Go 14 seconds with a cane; needs his arms to rise from a chair"
            },
            {
              "system": "Neurological",
              "finding": "Oriented; conversation, recall, and reasoning normal by direct observation; reduced ankle reflexes"
            },
            {
              "system": "Psychiatric",
              "finding": "Euthymic and engaged; judgment and insight intact"
            },
            {
              "system": "Skin",
              "finding": "No suspicious lesions on the exposed skin"
            }
          ],
          "assessment_plan": [
            {
              "display": "Subsequent annual wellness visit completed",
              "assessment": "Health risk assessment reviewed, personalized prevention plan updated, and a large-print copy given. Depression and alcohol screens are negative. Cognition is normal by direct observation, and the Mini-Cog at the first visit two months ago was 5 of 5, so it was not repeated. Fall risk is high",
              "plan": [
                "Next annual wellness visit in one year"
              ]
            },
            {
              "problem_id": "PRB-001",
              "display": "Type 2 diabetes with diabetic autonomic neuropathy",
              "assessment": "HbA1c 8.6% at the first visit, above his individualized goal below 7.5%. Home readings have improved since sitagliptin was added, with no hypoglycemia. Kidney screening is current: urine albumin-creatinine ratio 18 mg/g and eGFR 72 mL/min/1.73 m², both normal",
              "plan": [
                "Continue metformin 1000 mg twice daily and sitagliptin 100 mg daily",
                "HbA1c and lipids at the three-month review in about five weeks; urine albumin-creatinine ratio and eGFR yearly"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Neurogenic orthostatic hypotension",
              "assessment": "Standing systolic pressure 116 mmHg, up from 112 mmHg at the first visit, on midodrine 2.5 mg three times daily. Still mildly symptomatic",
              "plan": [
                "Continue midodrine with the last dose at least four hours before bed, staged standing, head-of-bed elevation, compression, and 2 liters of fluid a day",
                "Review the dose at the three-month visit, with a supine blood pressure check"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Diabetic peripheral neuropathy with loss of protective sensation",
              "assessment": "Foot examination today shows no ulcer or pre-ulcerative lesion; sensory loss unchanged",
              "plan": [
                "Daily self-inspection with a family member's help because of his vision",
                "Continue protective footwear; foot examination at every visit"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Primary open-angle glaucoma, severe stage",
              "assessment": "Eye pressures were above target at the first visit, and dorzolamide was added to latanoprost. The dilated eye examination two months ago also covered diabetic retinopathy screening. Neither drop lowers blood pressure or heart rate",
              "plan": [
                "Continue latanoprost and dorzolamide",
                "Eye pressure check at the three-month review; OCT and visual fields at six months with the eye clinic"
              ]
            },
            {
              "display": "High fall risk",
              "assessment": "Orthostatic hypotension, loss of foot sensation, leg weakness, low vision, and earlier falls. Timed Up and Go 14 seconds with a cane",
              "plan": [
                "Refer to physical therapy for gait, strength, and balance training",
                "Refer to low-vision rehabilitation for a home lighting and safety review, including a second stair handrail"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Influenza vaccine",
              "status": "up_to_date",
              "detail": "High-dose vaccine given last season; next dose due when the next season's vaccine is available"
            },
            {
              "service": "COVID-19 vaccine",
              "status": "due",
              "detail": "Recommended at his age and with diabetes; he will get it at his pharmacy"
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "up_to_date",
              "detail": "PCV20 given at the first visit two months ago; no further doses needed"
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "due",
              "detail": "Dose 1 planned for the three-month review, dose 2 two to six months later"
            },
            {
              "service": "RSV vaccine",
              "status": "due",
              "detail": "Recommended at 60 to 74 with diabetes and its complications; single dose before the respiratory season"
            },
            {
              "service": "Tetanus booster",
              "status": "due",
              "detail": "No booster on record; he will check his pharmacy records"
            },
            {
              "service": "Diabetic eye examination",
              "status": "up_to_date",
              "detail": "Dilated examination two months ago with the eye clinic, which follows his glaucoma and mild retinopathy; repeat yearly"
            },
            {
              "service": "Diabetic foot examination",
              "status": "completed_today",
              "detail": "No ulcer; loss of protective sensation known; examined at every visit"
            },
            {
              "service": "Kidney screening",
              "status": "up_to_date",
              "detail": "Urine albumin-creatinine ratio and eGFR normal at the first visit; repeat yearly"
            },
            {
              "service": "Cholesterol",
              "status": "up_to_date",
              "detail": "LDL 128 mg/dL before atorvastatin; repeat at the three-month review"
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 score 0"
            },
            {
              "service": "Alcohol misuse screening",
              "status": "completed_today",
              "detail": "AUDIT-C score 0"
            },
            {
              "service": "Cognitive assessment",
              "status": "completed_today",
              "detail": "Normal by direct observation; Mini-Cog 5 of 5 two months ago"
            },
            {
              "service": "Falls prevention",
              "status": "referred",
              "detail": "Physical therapy for gait and balance and low-vision rehabilitation for home safety",
              "guideline_ids": [
                "GL-USPSTF-FALLS-2024"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "ordered",
              "detail": "No screening result on file; stool FIT kit given, to be returned by mail",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "ordered",
              "detail": "One-time screening recommended for all adults through age 79; added to the three-month laboratory tests",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "not_indicated",
              "detail": "Not recommended at 70 or older"
            },
            {
              "service": "Lung cancer and abdominal aortic aneurysm screening",
              "status": "not_indicated",
              "detail": "No tobacco use is recorded in his social history"
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 20 minutes, with his consent. He has a written health care directive and has named a health care agent; a copy is now in the chart. He described what matters most to him: keeping the sight he has left, staying at home, and continuing to write and record. The discussion covered how to make his wishes known if he could not speak for himself and how to keep the directive with his agent. He will review his wishes with his agent and revisit them at a future visit.",
          "follow_up": "Physical therapy and low-vision rehabilitation referrals placed. Return the FIT kit by mail. Three-month diabetes, blood pressure, and eye pressure review in about five weeks, with HbA1c, lipids, hepatitis C screening, and the first zoster dose. Next annual wellness visit in one year",
          "guideline_ids": [
            "GL-AWV-CMS",
            "GL-PREV-2026",
            "GL-ADA-2025",
            "GL-CMID-2026"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic Medicare annual wellness visit; no synthetic illness episode is added under the recent-death rule.",
          "author": "The Human Record generator",
          "created": "2026-11-03T09:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-02-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 188,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 96.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 27.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 146,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 78,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic seated vital signs. Standing blood pressures for the orthostatic assessment are recorded in the functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-03-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 188,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 95.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.9,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 142,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 76,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic seated vital signs. Standing blood pressures for the orthostatic assessment are recorded in the functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-05-29",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 188,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 93.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 136,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 74,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 96,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic seated vital signs. Standing blood pressures for the orthostatic assessment are recorded in the functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-08-14",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 188,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 92.5,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.2,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 134,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 74,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 96,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic seated vital signs. Standing blood pressures for the orthostatic assessment are recorded in the functional status.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-04-24",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 188,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 94.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 26.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 138,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 75,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 95,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic seated vital signs at the annual wellness visit. The standing blood pressure is recorded in the visit examination.",
          "author": "The Human Record generator",
          "created": "2026-11-03T09:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "No tobacco use; no current alcohol use",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern substance-use history.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Past amphetamine and barbiturate use in his twenties and thirties, with residential treatment in his early fifties; no use since. Avoid prescribing controlled stimulants and sedatives, and review any opioid or benzodiazepine with him first",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0004",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern documentation of a historically documented, publicly disclosed history; not a current diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Occupation: recording artist and songwriter, now recording at home rather than touring",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern occupation echoing the historical role; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "Supports: a family member who comes to visits and fills his pill organizer, and his church community",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic strengths and supports.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Orthostatic vital signs at intake: 146/80 seated and 112/68 after three minutes standing, heart rate 78 to 82; lightheaded on standing and two falls in six months",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic orthostatic assessment showing a 34 mm Hg systolic drop with little heart rate rise, typical of neurogenic orthostatic hypotension.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "FUNC-002",
        "display": "Walks with a cane; reduced vibration and monofilament sensation to the ankles in both feet; independent in basic activities of daily living",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic functional status linked to his description of numb, weak legs.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "FUNC-003",
        "display": "Low vision from advanced glaucoma: tunnel vision in both eyes and difficulty in dim light; no longer drives",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic functional impact of vision loss.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, oriented, and wry; speaks frankly about his past substance use and his faith",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "MSE-002",
        "display": "Mood euthymic; PHQ-2 negative; Mini-Cog normal",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Type 2 diabetes above goal in a 71-year-old man with autonomic and peripheral neuropathy and orthostatic hypotension. Please confirm whether diabetic autonomic neuropathy explains his lightheadedness on standing, advise on treating it, and help choose add-on glucose-lowering therapy",
        "urgency": "Routine, within four weeks; to coincide with his diabetes check",
        "pertinent_history": "Lightheaded on standing, with two falls in six months; he walks with a cane. Seated blood pressure 146/80 mmHg, falling to 112/68 after three minutes standing, while heart rate rises only from 78 to 82. Numb feet with monofilament and vibration sensation reduced to the ankles. He was once told he had Shy-Drager syndrome and wants to know what he really has. HbA1c 8.6 percent on metformin 500 mg twice daily; eGFR 74, urine albumin-creatinine ratio 18 mg/g, vitamin B12 286 pg/mL, TSH and hemoglobin normal. Severe primary open-angle glaucoma with low vision, followed by the eye clinic; dorzolamide added to latanoprost today. No tobacco or alcohol use. Today metformin was raised to 1000 mg twice daily and atorvastatin 40 mg was started, and he began staged standing, head-of-bed elevation, waist-high compression, and 2 liters of fluid a day. No blood pressure medicine is used",
        "questions": [
          "Is diabetic autonomic neuropathy a sufficient explanation for his orthostatic hypotension, and should the earlier Shy-Drager label be carried forward?",
          "If the non-drug measures are not enough, which medicine do you recommend, and how should we watch for high pressure lying down?",
          "Which add-on glucose-lowering agent is safest, given his risk of unrecognized low glucose, his falls, and his orthostatic hypotension?",
          "Do you agree with an HbA1c goal below 7.5 percent?",
          "Should his seated blood pressure above 130/80 be treated?"
        ]
      },
      "consultant_note": {
        "history": "Mr. Cash is seen at the request of Dr. Hale, on the same day as his four-week diabetes check. Since the first visit he has taken metformin 1000 mg twice daily without stomach upset, and his fasting home glucose readings run 140 to 170 mg/dL, with none below 70 and no shakiness, sweating, or confusion. He stands up in stages, has raised the head of his bed, wears waist-high compression, and drinks about 2 liters a day. He is still lightheaded on standing most mornings and after meals, but he has had no further falls and no fainting. He has no nausea, diarrhea, early fullness, or difficulty passing urine. His feet are numb to the ankles, unchanged. He asks what is causing the lightheadedness",
        "data_reviewed": "The intake HbA1c, kidney function, urine albumin-creatinine ratio, vitamin B12, TSH, and hemoglobin; today's basic metabolic panel; the intake and today's lying, seated, and standing blood pressures and heart rates; and his home glucose log",
        "exam": [
          {
            "system": "General",
            "finding": "Alert and wry; walks in with a cane"
          },
          {
            "system": "Cardiovascular",
            "finding": "Regular rhythm; blood pressure 150/84 mmHg lying, 142/78 mmHg seated, and 110/68 mmHg after three minutes standing, with heart rate 76 rising only to 80, and lightheadedness"
          },
          {
            "system": "Feet",
            "finding": "Skin intact; no ulcers or calluses; monofilament and vibration sensation reduced to the ankles; pedal pulses present"
          },
          {
            "system": "Neurological",
            "finding": "Reduced ankle reflexes; stocking sensory loss in both legs"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-002",
            "display": "Neurogenic orthostatic hypotension from diabetic autonomic neuropathy",
            "assessment": "Systolic pressure falls 32 mmHg from sitting to standing while heart rate rises only 4 beats per minute, the same pattern as at intake: a neurogenic cause. With long-standing diabetes and length-dependent sensory loss, diabetic autonomic neuropathy explains it, and the earlier Shy-Drager label is not carried forward. Formal autonomic testing would not change treatment. He is still symptomatic on non-drug measures, and lying pressure of 150/84 mmHg allows a low dose of a pressor"
          },
          {
            "problem_id": "PRB-001",
            "display": "Type 2 diabetes with diabetic autonomic neuropathy",
            "assessment": "HbA1c 8.6 percent, above an individualized goal below 7.5 percent that suits his age, neuropathy, falls, and low vision. Autonomic neuropathy can blunt the warning signs of low glucose, so insulin and sulfonylureas are avoided. An SGLT2 inhibitor would add fluid loss to his orthostatic hypotension, and a GLP-1 receptor agonist's nausea, slowed stomach emptying, and weight loss are poorly tolerated with autonomic neuropathy; he has no atherosclerotic disease, heart failure, or kidney disease that would make either essential. Sitagliptin carries little risk of low glucose and does not lower blood pressure, and eGFR 72 allows the full dose"
          },
          {
            "problem_id": "PRB-003",
            "display": "Diabetic peripheral neuropathy with loss of protective sensation",
            "assessment": "No ulcer or pre-ulcerative lesion. Vitamin B12 286 pg/mL is low-normal on metformin and should be watched"
          }
        ],
        "recommendations": [
          "Start midodrine 2.5 mg on waking, at midday, and mid-afternoon, with the last dose at least four hours before bed. If he is still symptomatic and lying pressure allows, increase to 5 mg three times daily",
          "Continue staged standing, head-of-bed elevation, compression, and fluids",
          "Check lying, seated, and standing pressure at each visit to watch for high pressure lying down; avoid fludrocortisone, which raises lying pressure and lowers potassium",
          "No blood pressure medicine for the seated readings while standing pressure is low",
          "Start sitagliptin 100 mg daily and continue metformin 1000 mg twice daily",
          "HbA1c goal below 7.5 percent; HbA1c at the three-month review",
          "Avoid insulin and sulfonylureas",
          "Vitamin B12 periodically while on metformin",
          "Keep avoiding eye drops that slow the heart or lower blood pressure, such as timolol and brimonidine"
        ],
        "communication": "Discussed with Dr. Hale in person today; the patient agrees with the plan",
        "follow_up": "Primary care will manage titration and monitoring on the CMID schedule. Endocrinology will see him again if HbA1c stays above goal on two agents, if he has low glucose, or if orthostatic symptoms or falls continue despite midodrine"
      },
      "guideline_ids": [
        "GL-ADA-2025",
        "GL-CMID-2026"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "Lightheaded when he stands and afraid of another fall; was once told he had Shy-Drager syndrome and wants to know what he really has",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "Wants to keep the sight he has left so he can keep writing songs",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Reach an HbA1c below 7.5% without hypoglycemia by the six-month review",
        "status": "completed",
        "target_date": "2026-08-14",
        "outcome": "HbA1c fell from 8.6% to 7.3% with no hypoglycemia",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic individualized glycemic goal for an older adult with neuropathy.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "No falls and a standing systolic pressure of 100 mm Hg or more by the six-month review",
        "status": "completed",
        "target_date": "2026-08-14",
        "outcome": "No falls since the second visit; 134/74 seated and 120/70 standing on midodrine",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic orthostatic hypotension goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Lower intraocular pressure to 16 mm Hg or less in each eye by the three-month review",
        "status": "completed",
        "target_date": "2026-05-29",
        "outcome": "Pressure 15 mm Hg right and 16 mm Hg left at three months",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic target pressure for advanced glaucoma.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "LDL cholesterol below 70 mg/dL by the six-month review",
        "status": "active",
        "target_date": "2026-08-14",
        "outcome": "LDL 74 mg/dL at three months; recheck at the annual visit",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lipid goal.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Increase metformin to 1000 mg twice daily and set an individualized HbA1c goal below 7.5%; avoid insulin and sulfonylureas while autonomic neuropathy may blunt warning symptoms of hypoglycemia",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0002"
          ],
          "synthetic_reason": "Synthetic glycemic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Endocrinology consultation to confirm diabetic autonomic neuropathy as the cause of orthostatic hypotension, reconsider the earlier Shy-Drager label, and choose add-on glucose-lowering therapy",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0006",
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Treat neurogenic orthostatic hypotension: stand up in stages, raise the head of the bed, use waist-high compression, drink 2 liters of fluid a day, then midodrine with the last dose at least four hours before bed; check supine blood pressure at each visit",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic orthostatic hypotension plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Check HbA1c every three months until at goal, a basic metabolic panel, UACR, and lipids each year, lipids 4 to 12 weeks after starting a statin, and vitamin B12 periodically on metformin",
        "status": "completed",
        "guideline_ids": [
          "GL-CMID-2026",
          "GL-ADA-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic laboratory monitoring on the CMID diabetes schedule.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Examine the feet at every visit because of sensory loss; daily self-inspection and protective footwear",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0007"
          ],
          "synthetic_reason": "Synthetic foot-care plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-006",
        "display": "Coordinate glaucoma care with the eye clinic: add dorzolamide to latanoprost, check pressure at each visit, and repeat OCT and visual fields every six months; avoid timolol and brimonidine because of bradycardia, bronchospasm, and low blood pressure",
        "status": "completed",
        "guideline_ids": [
          "GL-AAO-POAG-2025",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic glaucoma plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-007",
        "display": "Annual dilated eye examination for diabetic retinopathy; low-vision rehabilitation and home lighting review",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-2025",
          "GL-AAO-POAG-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic eye-care plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      },
      {
        "id": "INT-008",
        "display": "Start atorvastatin 40 mg; give PCV20 and recombinant zoster vaccines",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic cardiovascular risk and vaccination plan.",
          "author": "The Human Record generator",
          "created": "2026-11-02T15:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-ADA-2025",
        "title": "Standards of Care in Diabetes—2025",
        "publisher": "American Diabetes Association",
        "url": "https://diabetesjournals.org/care/issue/48/Supplement_1",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-AAO-POAG-2025",
        "title": "Primary Open-Angle Glaucoma Preferred Practice Pattern",
        "publisher": "American Academy of Ophthalmology",
        "url": "https://doi.org/10.1016/j.ophtha.2025.12.029",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, diabetes, glaucoma, and hyperlipidemia monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AWV-CMS",
        "title": "Medicare Wellness Visits (Medicare Learning Network)",
        "publisher": "Centers for Medicare & Medicaid Services",
        "url": "https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-FALLS-2024",
        "title": "Falls Prevention in Community-Dwelling Older Adults: Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-community-dwelling-older-adults-interventions",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Recent-death rule: only facts Cash, his manager, or published reference works made public are used. Encyclopedia of Arkansas, ABC News, CNN transcript, and Pollstar logged."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Historical substance use is recorded as history, marked sensitive, and is not a modern diagnosis. Death recorded without graphic detail."
    }
  }
}
